MA46927A - Procédés de détection du cancer - Google Patents

Procédés de détection du cancer

Info

Publication number
MA46927A
MA46927A MA046927A MA46927A MA46927A MA 46927 A MA46927 A MA 46927A MA 046927 A MA046927 A MA 046927A MA 46927 A MA46927 A MA 46927A MA 46927 A MA46927 A MA 46927A
Authority
MA
Morocco
Prior art keywords
detection methods
cancer detection
cancer
methods
detection
Prior art date
Application number
MA046927A
Other languages
English (en)
Inventor
Robert Feldman
Melanie Mahtani
Original Assignee
Prime Genomics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prime Genomics Inc filed Critical Prime Genomics Inc
Publication of MA46927A publication Critical patent/MA46927A/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
MA046927A 2016-11-22 2017-11-22 Procédés de détection du cancer MA46927A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201662425549P 2016-11-22 2016-11-22

Publications (1)

Publication Number Publication Date
MA46927A true MA46927A (fr) 2019-10-02

Family

ID=62195635

Family Applications (1)

Application Number Title Priority Date Filing Date
MA046927A MA46927A (fr) 2016-11-22 2017-11-22 Procédés de détection du cancer

Country Status (8)

Country Link
US (1) US20200081008A1 (fr)
EP (1) EP3544605A4 (fr)
JP (2) JP2020511933A (fr)
CN (1) CN110198711A (fr)
CA (1) CA3044257A1 (fr)
MA (1) MA46927A (fr)
MX (1) MX2019006005A (fr)
WO (1) WO2018098379A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3044257A1 (fr) * 2016-11-22 2018-05-31 Prime Genomics, Inc. Procedes de detection du cancer
CN108830045B (zh) * 2018-06-29 2021-04-20 深圳先进技术研究院 一种基于多组学的生物标记物系统筛选方法
KR102211972B1 (ko) * 2018-08-02 2021-02-04 엑소젠 피티이. 엘티디 액체생검 다중 암 유전자 바이오마커를 이용한 유방암 조기진단 및 치료 후 모니터링 방법
US20220178924A1 (en) * 2019-03-03 2022-06-09 Purdue Research Foundation Systems and methods for identifying subtype, prognosis, and monitoring of breast cancer
CN111679076A (zh) * 2020-06-15 2020-09-18 吉林医药学院 一种用于检测cyclinD1和BCL-2抗体的检测试剂盒
EP4165206A2 (fr) * 2020-06-16 2023-04-19 Grail, LLC Procédés d'analyse d'arn acellulaire
CN111979321B (zh) * 2020-08-26 2022-07-12 郑州大学第一附属医院 用于胰腺癌检查的基因标记物
CN115927610A (zh) * 2022-07-19 2023-04-07 武汉艾米森生命科技有限公司 检测foxo6基因中目标区域的甲基化水平的试剂在制备膀胱癌诊断产品中的应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294349B1 (en) * 1999-03-01 2001-09-25 University Of Mississippi Medical Ctr. Method of diagnosing and monitoring malignant breast carcinomas
US6358683B1 (en) * 1999-06-03 2002-03-19 The Regents Of The University Of California Blood-based assays for breast cancer
JP2008073304A (ja) * 2006-09-22 2008-04-03 Gifu Univ 超音波乳房診断システム
GB201000688D0 (en) * 2010-01-15 2010-03-03 Diagenic Asa Product and method
US9624547B2 (en) * 2010-02-10 2017-04-18 The Regents Of The University Of California Salivary transcriptomic and proteomic biomarkers for breast cancer detection
CN102971737A (zh) * 2010-07-08 2013-03-13 第一基因股份有限公司 用于复杂网络中的全系统动力学的量化的系统
US20140141986A1 (en) * 2011-02-22 2014-05-22 David Spetzler Circulating biomarkers
KR101335034B1 (ko) * 2011-08-25 2013-12-02 주식회사 바이오인프라 유방암 진단을 위한 엑소좀 내의 ＡＮＴ2 ｍＲＮＡ의 이용방법
WO2015116868A2 (fr) * 2014-01-29 2015-08-06 Caris Mpi, Inc. Profilage moléculaire de modulateurs immunitaires
EP3152579A4 (fr) * 2014-06-04 2018-01-17 Atossa Genetics Inc. Mammographie moléculaire
WO2016004387A1 (fr) * 2014-07-02 2016-01-07 H. Lee Moffitt Cancer Center And Research Institute, Inc. Signature d'expression génique utilisable à des fins de pronostic du cancer
CA3044257A1 (fr) * 2016-11-22 2018-05-31 Prime Genomics, Inc. Procedes de detection du cancer

Also Published As

Publication number Publication date
EP3544605A1 (fr) 2019-10-02
MX2019006005A (es) 2019-10-02
EP3544605A4 (fr) 2020-11-25
WO2018098379A1 (fr) 2018-05-31
JP2020511933A (ja) 2020-04-23
CN110198711A (zh) 2019-09-03
US20200081008A1 (en) 2020-03-12
CA3044257A1 (fr) 2018-05-31
JP2022163076A (ja) 2022-10-25

Similar Documents

Publication Publication Date Title
CL2018001116A1 (es) Endulzantes de alta densidad
DK3538864T3 (da) Mikrotom
MA55748A (fr) Procédés de détection d'aav
DK3425055T3 (da) Molekylært detekterings-/diagnosereagens til tumor
MA46927A (fr) Procédés de détection du cancer
DE112015004842T8 (de) Ultraschallobjekterfassungsvorrichtung
DK3126395T3 (da) Multispecifikke antistoffer
BR112016016020A2 (pt) anticorpos dirigidos contra interleucina-33 (il-33)
DK3140653T3 (da) Direkte immunhistokemianalyse
IL231111A0 (en) flash detection
DE112016000423T8 (de) Abschnittslinienerkennungsvorrichtung
KR20180084858A (ko) 포커스 검출
DK3364189T3 (da) Immunkromatografisk teststykke
GB201608000D0 (en) Chromosome detection
DK3511705T3 (da) Detekteringsanordning
GB201602210D0 (en) Detection of cancer
IT201600092505A1 (it) Dispositivo di rilevazione di posizione
BR112017007401A2 (pt) métodos de detecção específicos
DE112017004618T8 (de) Objekterfassungsvorrichtung
FR3042666B1 (fr) Detection de signal ultra large bande
GB201619509D0 (en) Sample detection device
MA50130A (fr) Détecteur de position
IL257514A (en) A method for detecting cancer
BR112017001926A2 (pt) processamento de eletrofluido
GB201603716D0 (en) Detection device